nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—Corticosteroid Hormone Receptor Agonists—Prednisone—systemic scleroderma	0.312	1	CiPCiCtD
Desonide—Mometasone—systemic scleroderma	0.192	0.647	CrCtD
Desonide—NR3C1—Mometasone—systemic scleroderma	0.109	0.758	CbGbCtD
Desonide—Prednisone—systemic scleroderma	0.105	0.353	CrCtD
Desonide—NR3C1—Prednisone—systemic scleroderma	0.0346	0.241	CbGbCtD
Desonide—Fluocinonide—Mometasone—systemic scleroderma	0.00593	0.0277	CrCrCtD
Desonide—Prednicarbate—Mometasone—systemic scleroderma	0.00593	0.0277	CrCrCtD
Desonide—Testolactone—Mometasone—systemic scleroderma	0.00593	0.0277	CrCrCtD
Desonide—Beclomethasone—Mometasone—systemic scleroderma	0.00593	0.0277	CrCrCtD
Desonide—Clocortolone—Mometasone—systemic scleroderma	0.00593	0.0277	CrCrCtD
Desonide—Fluocortolone—Mometasone—systemic scleroderma	0.00576	0.0269	CrCrCtD
Desonide—Fluocinolone Acetonide—Mometasone—systemic scleroderma	0.0056	0.0262	CrCrCtD
Desonide—Alclometasone—Mometasone—systemic scleroderma	0.0056	0.0262	CrCrCtD
Desonide—Amcinonide—Mometasone—systemic scleroderma	0.00545	0.0255	CrCrCtD
Desonide—Budesonide—Mometasone—systemic scleroderma	0.00545	0.0255	CrCrCtD
Desonide—Fludrocortisone—Mometasone—systemic scleroderma	0.00531	0.0248	CrCrCtD
Desonide—Flunisolide—Mometasone—systemic scleroderma	0.00531	0.0248	CrCrCtD
Desonide—Clobetasol propionate—Mometasone—systemic scleroderma	0.00531	0.0248	CrCrCtD
Desonide—Prednisone—Mometasone—systemic scleroderma	0.00531	0.0248	CrCrCtD
Desonide—Diflorasone—Mometasone—systemic scleroderma	0.00531	0.0248	CrCrCtD
Desonide—Paramethasone—Mometasone—systemic scleroderma	0.00518	0.0242	CrCrCtD
Desonide—Desoximetasone—Mometasone—systemic scleroderma	0.00505	0.0236	CrCrCtD
Desonide—Fluprednidene Acetate—Mometasone—systemic scleroderma	0.00493	0.0231	CrCrCtD
Desonide—Loteprednol—Mometasone—systemic scleroderma	0.00493	0.0231	CrCrCtD
Desonide—Fluorometholone—Mometasone—systemic scleroderma	0.00493	0.0231	CrCrCtD
Desonide—Triamcinolone—Mometasone—systemic scleroderma	0.00493	0.0231	CrCrCtD
Desonide—Rimexolone—Mometasone—systemic scleroderma	0.00482	0.0225	CrCrCtD
Desonide—Betamethasone—Mometasone—systemic scleroderma	0.00482	0.0225	CrCrCtD
Desonide—Dexamethasone—Mometasone—systemic scleroderma	0.00482	0.0225	CrCrCtD
Desonide—Methylprednisolone—Mometasone—systemic scleroderma	0.00461	0.0215	CrCrCtD
Desonide—Prednisolone—Mometasone—systemic scleroderma	0.00451	0.0211	CrCrCtD
Desonide—Hydrocortisone—Mometasone—systemic scleroderma	0.00433	0.0202	CrCrCtD
Desonide—Ciclesonide—Prednisone—systemic scleroderma	0.00411	0.0192	CrCrCtD
Desonide—Hydrocortamate—Prednisone—systemic scleroderma	0.00344	0.0161	CrCrCtD
Desonide—Prednicarbate—Prednisone—systemic scleroderma	0.00323	0.0151	CrCrCtD
Desonide—Testolactone—Prednisone—systemic scleroderma	0.00323	0.0151	CrCrCtD
Desonide—Fluocortolone—Prednisone—systemic scleroderma	0.00314	0.0147	CrCrCtD
Desonide—Alclometasone—Prednisone—systemic scleroderma	0.00305	0.0143	CrCrCtD
Desonide—Amcinonide—Prednisone—systemic scleroderma	0.00297	0.0139	CrCrCtD
Desonide—Budesonide—Prednisone—systemic scleroderma	0.00297	0.0139	CrCrCtD
Desonide—Fludrocortisone—Prednisone—systemic scleroderma	0.0029	0.0135	CrCrCtD
Desonide—Clobetasol propionate—Prednisone—systemic scleroderma	0.0029	0.0135	CrCrCtD
Desonide—Flunisolide—Prednisone—systemic scleroderma	0.0029	0.0135	CrCrCtD
Desonide—Diflorasone—Prednisone—systemic scleroderma	0.0029	0.0135	CrCrCtD
Desonide—Paramethasone—Prednisone—systemic scleroderma	0.00282	0.0132	CrCrCtD
Desonide—Desoximetasone—Prednisone—systemic scleroderma	0.00275	0.0129	CrCrCtD
Desonide—Loteprednol—Prednisone—systemic scleroderma	0.00269	0.0126	CrCrCtD
Desonide—Fluorometholone—Prednisone—systemic scleroderma	0.00269	0.0126	CrCrCtD
Desonide—Mometasone—Prednisone—systemic scleroderma	0.00269	0.0126	CrCrCtD
Desonide—Triamcinolone—Prednisone—systemic scleroderma	0.00269	0.0126	CrCrCtD
Desonide—Fluprednidene Acetate—Prednisone—systemic scleroderma	0.00269	0.0126	CrCrCtD
Desonide—Dexamethasone—Prednisone—systemic scleroderma	0.00263	0.0123	CrCrCtD
Desonide—Rimexolone—Prednisone—systemic scleroderma	0.00263	0.0123	CrCrCtD
Desonide—Betamethasone—Prednisone—systemic scleroderma	0.00263	0.0123	CrCrCtD
Desonide—Methylprednisolone—Prednisone—systemic scleroderma	0.00251	0.0117	CrCrCtD
Desonide—Prednisolone—Prednisone—systemic scleroderma	0.00246	0.0115	CrCrCtD
Desonide—Hydrocortisone—Prednisone—systemic scleroderma	0.00236	0.011	CrCrCtD
Desonide—Dermatitis perioral—Mometasone—systemic scleroderma	0.00144	0.0428	CcSEcCtD
Desonide—Telangiectasia—Mometasone—systemic scleroderma	0.00139	0.0413	CcSEcCtD
Desonide—Acneiform eruption—Mometasone—systemic scleroderma	0.0013	0.0385	CcSEcCtD
Desonide—Miliaria—Mometasone—systemic scleroderma	0.00111	0.0331	CcSEcCtD
Desonide—Secondary infection—Mometasone—systemic scleroderma	0.00111	0.0331	CcSEcCtD
Desonide—Skin atrophy—Mometasone—systemic scleroderma	0.00108	0.0322	CcSEcCtD
Desonide—Skin striae—Mometasone—systemic scleroderma	0.00103	0.0306	CcSEcCtD
Desonide—Dermatitis acneiform—Mometasone—systemic scleroderma	0.000958	0.0285	CcSEcCtD
Desonide—Allergic contact dermatitis—Mometasone—systemic scleroderma	0.000937	0.0278	CcSEcCtD
Desonide—Secondary infection—Azathioprine—systemic scleroderma	0.000854	0.0254	CcSEcCtD
Desonide—Leukoderma—Mometasone—systemic scleroderma	0.00077	0.0229	CcSEcCtD
Desonide—Atrophy—Mycophenolic acid—systemic scleroderma	0.000694	0.0206	CcSEcCtD
Desonide—Atrophy—Mycophenolate mofetil—systemic scleroderma	0.000547	0.0163	CcSEcCtD
Desonide—Folliculitis—Mometasone—systemic scleroderma	0.000521	0.0155	CcSEcCtD
Desonide—Telangiectasia—Prednisone—systemic scleroderma	0.000513	0.0152	CcSEcCtD
Desonide—Acneiform eruption—Prednisone—systemic scleroderma	0.000479	0.0142	CcSEcCtD
Desonide—Telangiectasia—Methotrexate—systemic scleroderma	0.000429	0.0127	CcSEcCtD
Desonide—Stinging—Mometasone—systemic scleroderma	0.000404	0.012	CcSEcCtD
Desonide—Skin atrophy—Prednisone—systemic scleroderma	0.0004	0.0119	CcSEcCtD
Desonide—Skin striae—Prednisone—systemic scleroderma	0.00038	0.0113	CcSEcCtD
Desonide—Atrophy—Prednisone—systemic scleroderma	0.000371	0.011	CcSEcCtD
Desonide—Viral infection—Mometasone—systemic scleroderma	0.000362	0.0108	CcSEcCtD
Desonide—Dermatitis acneiform—Prednisone—systemic scleroderma	0.000354	0.0105	CcSEcCtD
Desonide—Dermatitis contact—Mometasone—systemic scleroderma	0.000324	0.00961	CcSEcCtD
Desonide—Blood pressure increased—Captopril—systemic scleroderma	0.000288	0.00854	CcSEcCtD
Desonide—Leukoderma—Prednisone—systemic scleroderma	0.000284	0.00845	CcSEcCtD
Desonide—Rash pustular—Mycophenolic acid—systemic scleroderma	0.000283	0.00842	CcSEcCtD
Desonide—Viral infection—Mycophenolic acid—systemic scleroderma	0.00025	0.00744	CcSEcCtD
Desonide—Leukoderma—Methotrexate—systemic scleroderma	0.000238	0.00706	CcSEcCtD
Desonide—Blood pressure increased—Leflunomide—systemic scleroderma	0.000237	0.00704	CcSEcCtD
Desonide—Dermatitis contact—Leflunomide—systemic scleroderma	0.000234	0.00696	CcSEcCtD
Desonide—Blood pressure increased—Mycophenolic acid—systemic scleroderma	0.000226	0.00672	CcSEcCtD
Desonide—Viral infection—Lisinopril—systemic scleroderma	0.000225	0.0067	CcSEcCtD
Desonide—Rash pustular—Mycophenolate mofetil—systemic scleroderma	0.000224	0.00665	CcSEcCtD
Desonide—Infestation—Pentoxifylline—systemic scleroderma	0.000212	0.0063	CcSEcCtD
Desonide—Infestation NOS—Pentoxifylline—systemic scleroderma	0.000212	0.0063	CcSEcCtD
Desonide—Asthma—Mometasone—systemic scleroderma	0.000205	0.0061	CcSEcCtD
Desonide—Sweating—Pentoxifylline—systemic scleroderma	0.000203	0.00604	CcSEcCtD
Desonide—Upper respiratory tract infection—Mometasone—systemic scleroderma	0.000191	0.00567	CcSEcCtD
Desonide—Erythema—Pentoxifylline—systemic scleroderma	0.000166	0.00493	CcSEcCtD
Desonide—Pharyngitis—Mometasone—systemic scleroderma	0.000163	0.00485	CcSEcCtD
Desonide—Folliculitis—Methotrexate—systemic scleroderma	0.000161	0.00478	CcSEcCtD
Desonide—Asthma—Leflunomide—systemic scleroderma	0.000149	0.00442	CcSEcCtD
Desonide—Mediastinal disorder—Mometasone—systemic scleroderma	0.000148	0.0044	CcSEcCtD
Desonide—Pharyngitis—Captopril—systemic scleroderma	0.000143	0.00426	CcSEcCtD
Desonide—Asthma—Mycophenolic acid—systemic scleroderma	0.000142	0.00421	CcSEcCtD
Desonide—Irritability—Lisinopril—systemic scleroderma	0.000141	0.00419	CcSEcCtD
Desonide—Infestation—Azathioprine—systemic scleroderma	0.00014	0.00417	CcSEcCtD
Desonide—Infestation NOS—Azathioprine—systemic scleroderma	0.00014	0.00417	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.00014	0.00417	CcSEcCtD
Desonide—Upper respiratory tract infection—Leflunomide—systemic scleroderma	0.000138	0.0041	CcSEcCtD
Desonide—Infection—Pentoxifylline—systemic scleroderma	0.000134	0.00399	CcSEcCtD
Desonide—Hyperglycaemia—Leflunomide—systemic scleroderma	0.000134	0.00398	CcSEcCtD
Desonide—Viral infection—Prednisone—systemic scleroderma	0.000134	0.00398	CcSEcCtD
Desonide—Infestation NOS—Leflunomide—systemic scleroderma	0.000133	0.00394	CcSEcCtD
Desonide—Infestation—Leflunomide—systemic scleroderma	0.000133	0.00394	CcSEcCtD
Desonide—Upper respiratory tract infection—Mycophenolic acid—systemic scleroderma	0.000132	0.00392	CcSEcCtD
Desonide—Skin disorder—Pentoxifylline—systemic scleroderma	0.000131	0.00391	CcSEcCtD
Desonide—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.000131	0.00389	CcSEcCtD
Desonide—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.000128	0.0038	CcSEcCtD
Desonide—Asthma—Lisinopril—systemic scleroderma	0.000128	0.00379	CcSEcCtD
Desonide—Infestation NOS—Mycophenolic acid—systemic scleroderma	0.000126	0.00376	CcSEcCtD
Desonide—Infestation—Mycophenolic acid—systemic scleroderma	0.000126	0.00376	CcSEcCtD
Desonide—Cough—Mometasone—systemic scleroderma	0.000125	0.00371	CcSEcCtD
Desonide—Sweating—Mycophenolic acid—systemic scleroderma	0.000121	0.0036	CcSEcCtD
Desonide—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.000119	0.00353	CcSEcCtD
Desonide—Pharyngitis—Leflunomide—systemic scleroderma	0.000118	0.00351	CcSEcCtD
Desonide—Oedema peripheral—Leflunomide—systemic scleroderma	0.000117	0.00348	CcSEcCtD
Desonide—Infection—Mometasone—systemic scleroderma	0.000116	0.00345	CcSEcCtD
Desonide—Skin exfoliation—Prednisone—systemic scleroderma	0.000115	0.00343	CcSEcCtD
Desonide—Hyperglycaemia—Lisinopril—systemic scleroderma	0.000115	0.00342	CcSEcCtD
Desonide—Mediastinal disorder—Azathioprine—systemic scleroderma	0.000114	0.00337	CcSEcCtD
Desonide—Pharyngitis—Mycophenolic acid—systemic scleroderma	0.000113	0.00335	CcSEcCtD
Desonide—Asthma—Mycophenolate mofetil—systemic scleroderma	0.000112	0.00333	CcSEcCtD
Desonide—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.000112	0.00332	CcSEcCtD
Desonide—Cough—Captopril—systemic scleroderma	0.00011	0.00326	CcSEcCtD
Desonide—Sweating—Lisinopril—systemic scleroderma	0.000109	0.00324	CcSEcCtD
Desonide—Mediastinal disorder—Leflunomide—systemic scleroderma	0.000107	0.00319	CcSEcCtD
Desonide—Mental disorder—Leflunomide—systemic scleroderma	0.000104	0.0031	CcSEcCtD
Desonide—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.000102	0.00304	CcSEcCtD
Desonide—Pharyngitis—Lisinopril—systemic scleroderma	0.000101	0.00301	CcSEcCtD
Desonide—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000101	0.003	CcSEcCtD
Desonide—Oedema peripheral—Lisinopril—systemic scleroderma	0.000101	0.00299	CcSEcCtD
Desonide—Pain—Mometasone—systemic scleroderma	9.99e-05	0.00297	CcSEcCtD
Desonide—Infestation NOS—Mycophenolate mofetil—systemic scleroderma	9.98e-05	0.00296	CcSEcCtD
Desonide—Infestation—Mycophenolate mofetil—systemic scleroderma	9.98e-05	0.00296	CcSEcCtD
Desonide—Mental disorder—Mycophenolic acid—systemic scleroderma	9.95e-05	0.00295	CcSEcCtD
Desonide—Skin exfoliation—Methotrexate—systemic scleroderma	9.65e-05	0.00287	CcSEcCtD
Desonide—Pruritus—Pentoxifylline—systemic scleroderma	9.58e-05	0.00284	CcSEcCtD
Desonide—Sweating—Mycophenolate mofetil—systemic scleroderma	9.57e-05	0.00284	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	9.27e-05	0.00276	CcSEcCtD
Desonide—Mediastinal disorder—Lisinopril—systemic scleroderma	9.22e-05	0.00274	CcSEcCtD
Desonide—Cough—Leflunomide—systemic scleroderma	9.04e-05	0.00269	CcSEcCtD
Desonide—Mental disorder—Lisinopril—systemic scleroderma	8.96e-05	0.00266	CcSEcCtD
Desonide—Erythema—Lisinopril—systemic scleroderma	8.9e-05	0.00264	CcSEcCtD
Desonide—Infection—Azathioprine—systemic scleroderma	8.89e-05	0.00264	CcSEcCtD
Desonide—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	8.89e-05	0.00264	CcSEcCtD
Desonide—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	8.83e-05	0.00262	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	8.76e-05	0.0026	CcSEcCtD
Desonide—Skin disorder—Azathioprine—systemic scleroderma	8.7e-05	0.00258	CcSEcCtD
Desonide—Cough—Mycophenolic acid—systemic scleroderma	8.62e-05	0.00256	CcSEcCtD
Desonide—Rash—Pentoxifylline—systemic scleroderma	8.53e-05	0.00254	CcSEcCtD
Desonide—Dermatitis—Pentoxifylline—systemic scleroderma	8.53e-05	0.00253	CcSEcCtD
Desonide—Headache—Pentoxifylline—systemic scleroderma	8.48e-05	0.00252	CcSEcCtD
Desonide—Infection—Leflunomide—systemic scleroderma	8.4e-05	0.0025	CcSEcCtD
Desonide—Irritability—Prednisone—systemic scleroderma	8.38e-05	0.00249	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	8.36e-05	0.00248	CcSEcCtD
Desonide—Nervous system disorder—Leflunomide—systemic scleroderma	8.29e-05	0.00246	CcSEcCtD
Desonide—Pruritus—Mometasone—systemic scleroderma	8.26e-05	0.00245	CcSEcCtD
Desonide—Skin disorder—Leflunomide—systemic scleroderma	8.21e-05	0.00244	CcSEcCtD
Desonide—Hyperhidrosis—Leflunomide—systemic scleroderma	8.17e-05	0.00243	CcSEcCtD
Desonide—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	8.07e-05	0.0024	CcSEcCtD
Desonide—Infection—Mycophenolic acid—systemic scleroderma	8.01e-05	0.00238	CcSEcCtD
Desonide—Nervous system disorder—Mycophenolic acid—systemic scleroderma	7.91e-05	0.00235	CcSEcCtD
Desonide—Mental disorder—Mycophenolate mofetil—systemic scleroderma	7.85e-05	0.00233	CcSEcCtD
Desonide—Skin disorder—Mycophenolic acid—systemic scleroderma	7.83e-05	0.00233	CcSEcCtD
Desonide—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	7.8e-05	0.00232	CcSEcCtD
Desonide—Cough—Lisinopril—systemic scleroderma	7.77e-05	0.00231	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	7.53e-05	0.00224	CcSEcCtD
Desonide—Rash—Mometasone—systemic scleroderma	7.36e-05	0.00219	CcSEcCtD
Desonide—Dermatitis—Mometasone—systemic scleroderma	7.36e-05	0.00219	CcSEcCtD
Desonide—Headache—Mometasone—systemic scleroderma	7.32e-05	0.00217	CcSEcCtD
Desonide—Pruritus—Captopril—systemic scleroderma	7.26e-05	0.00216	CcSEcCtD
Desonide—Pain—Leflunomide—systemic scleroderma	7.23e-05	0.00215	CcSEcCtD
Desonide—Infection—Lisinopril—systemic scleroderma	7.22e-05	0.00214	CcSEcCtD
Desonide—Skin disorder—Lisinopril—systemic scleroderma	7.06e-05	0.0021	CcSEcCtD
Desonide—Hyperhidrosis—Lisinopril—systemic scleroderma	7.02e-05	0.00209	CcSEcCtD
Desonide—Irritability—Methotrexate—systemic scleroderma	7e-05	0.00208	CcSEcCtD
Desonide—Pain—Mycophenolic acid—systemic scleroderma	6.9e-05	0.00205	CcSEcCtD
Desonide—Hyperglycaemia—Prednisone—systemic scleroderma	6.84e-05	0.00203	CcSEcCtD
Desonide—Cough—Mycophenolate mofetil—systemic scleroderma	6.81e-05	0.00202	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	6.59e-05	0.00196	CcSEcCtD
Desonide—Rash—Captopril—systemic scleroderma	6.47e-05	0.00192	CcSEcCtD
Desonide—Dermatitis—Captopril—systemic scleroderma	6.46e-05	0.00192	CcSEcCtD
Desonide—Headache—Captopril—systemic scleroderma	6.43e-05	0.00191	CcSEcCtD
Desonide—Asthma—Methotrexate—systemic scleroderma	6.34e-05	0.00188	CcSEcCtD
Desonide—Infection—Mycophenolate mofetil—systemic scleroderma	6.32e-05	0.00188	CcSEcCtD
Desonide—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	6.24e-05	0.00185	CcSEcCtD
Desonide—Pain—Lisinopril—systemic scleroderma	6.21e-05	0.00185	CcSEcCtD
Desonide—Skin disorder—Mycophenolate mofetil—systemic scleroderma	6.18e-05	0.00184	CcSEcCtD
Desonide—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	6.15e-05	0.00183	CcSEcCtD
Desonide—Pruritus—Leflunomide—systemic scleroderma	5.98e-05	0.00178	CcSEcCtD
Desonide—Upper respiratory tract infection—Methotrexate—systemic scleroderma	5.89e-05	0.00175	CcSEcCtD
Desonide—Pruritus—Mycophenolic acid—systemic scleroderma	5.71e-05	0.0017	CcSEcCtD
Desonide—Infestation NOS—Methotrexate—systemic scleroderma	5.65e-05	0.00168	CcSEcCtD
Desonide—Infestation—Methotrexate—systemic scleroderma	5.65e-05	0.00168	CcSEcCtD
Desonide—Rash—Azathioprine—systemic scleroderma	5.64e-05	0.00168	CcSEcCtD
Desonide—Dermatitis—Azathioprine—systemic scleroderma	5.64e-05	0.00168	CcSEcCtD
Desonide—Headache—Azathioprine—systemic scleroderma	5.61e-05	0.00167	CcSEcCtD
Desonide—Pain—Mycophenolate mofetil—systemic scleroderma	5.44e-05	0.00162	CcSEcCtD
Desonide—Sweating—Methotrexate—systemic scleroderma	5.42e-05	0.00161	CcSEcCtD
Desonide—Rash—Leflunomide—systemic scleroderma	5.33e-05	0.00158	CcSEcCtD
Desonide—Dermatitis—Leflunomide—systemic scleroderma	5.33e-05	0.00158	CcSEcCtD
Desonide—Mental disorder—Prednisone—systemic scleroderma	5.32e-05	0.00158	CcSEcCtD
Desonide—Headache—Leflunomide—systemic scleroderma	5.3e-05	0.00157	CcSEcCtD
Desonide—Erythema—Prednisone—systemic scleroderma	5.29e-05	0.00157	CcSEcCtD
Desonide—Pruritus—Lisinopril—systemic scleroderma	5.14e-05	0.00153	CcSEcCtD
Desonide—Rash—Mycophenolic acid—systemic scleroderma	5.09e-05	0.00151	CcSEcCtD
Desonide—Dermatitis—Mycophenolic acid—systemic scleroderma	5.08e-05	0.00151	CcSEcCtD
Desonide—Headache—Mycophenolic acid—systemic scleroderma	5.05e-05	0.0015	CcSEcCtD
Desonide—Pharyngitis—Methotrexate—systemic scleroderma	5.04e-05	0.0015	CcSEcCtD
Desonide—Rash—Lisinopril—systemic scleroderma	4.58e-05	0.00136	CcSEcCtD
Desonide—Dermatitis—Lisinopril—systemic scleroderma	4.58e-05	0.00136	CcSEcCtD
Desonide—Mediastinal disorder—Methotrexate—systemic scleroderma	4.57e-05	0.00136	CcSEcCtD
Desonide—Headache—Lisinopril—systemic scleroderma	4.55e-05	0.00135	CcSEcCtD
Desonide—Pruritus—Mycophenolate mofetil—systemic scleroderma	4.5e-05	0.00134	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	4.47e-05	0.00133	CcSEcCtD
Desonide—Mental disorder—Methotrexate—systemic scleroderma	4.45e-05	0.00132	CcSEcCtD
Desonide—Erythema—Methotrexate—systemic scleroderma	4.42e-05	0.00131	CcSEcCtD
Desonide—Infection—Prednisone—systemic scleroderma	4.29e-05	0.00127	CcSEcCtD
Desonide—Nervous system disorder—Prednisone—systemic scleroderma	4.23e-05	0.00126	CcSEcCtD
Desonide—Skin disorder—Prednisone—systemic scleroderma	4.19e-05	0.00124	CcSEcCtD
Desonide—Hyperhidrosis—Prednisone—systemic scleroderma	4.17e-05	0.00124	CcSEcCtD
Desonide—Rash—Mycophenolate mofetil—systemic scleroderma	4.01e-05	0.00119	CcSEcCtD
Desonide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	4.01e-05	0.00119	CcSEcCtD
Desonide—Headache—Mycophenolate mofetil—systemic scleroderma	3.99e-05	0.00118	CcSEcCtD
Desonide—Cough—Methotrexate—systemic scleroderma	3.86e-05	0.00115	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	3.74e-05	0.00111	CcSEcCtD
Desonide—Infection—Methotrexate—systemic scleroderma	3.58e-05	0.00106	CcSEcCtD
Desonide—Nervous system disorder—Methotrexate—systemic scleroderma	3.54e-05	0.00105	CcSEcCtD
Desonide—Skin disorder—Methotrexate—systemic scleroderma	3.5e-05	0.00104	CcSEcCtD
Desonide—Hyperhidrosis—Methotrexate—systemic scleroderma	3.49e-05	0.00104	CcSEcCtD
Desonide—Pain—Methotrexate—systemic scleroderma	3.08e-05	0.000916	CcSEcCtD
Desonide—Pruritus—Prednisone—systemic scleroderma	3.05e-05	0.000907	CcSEcCtD
Desonide—Rash—Prednisone—systemic scleroderma	2.72e-05	0.000808	CcSEcCtD
Desonide—Dermatitis—Prednisone—systemic scleroderma	2.72e-05	0.000807	CcSEcCtD
Desonide—Headache—Prednisone—systemic scleroderma	2.7e-05	0.000803	CcSEcCtD
Desonide—Pruritus—Methotrexate—systemic scleroderma	2.55e-05	0.000758	CcSEcCtD
Desonide—Rash—Methotrexate—systemic scleroderma	2.27e-05	0.000675	CcSEcCtD
Desonide—Dermatitis—Methotrexate—systemic scleroderma	2.27e-05	0.000675	CcSEcCtD
Desonide—Headache—Methotrexate—systemic scleroderma	2.26e-05	0.000671	CcSEcCtD
